Jeffrey H. Goodman, Ph.D.
Dr. Goodman is a Research Scientist in the Neurology Research Center. He has co-authored 50 journal articles, abstracts and book chapters all in the field of epilepsy. Dr. Goodman received a BS degree in Biology from Syracuse University and his Ph.D. in Physiology from the University of Texas, Southwestern Medical School in Dallas. Dr. Goodman continued his postdoctoral training in the Neurology Department of the VA Medical Center in Dallas and was a member of the Neurology Faculty at Southwestern Medical School before joining HHH. While interested in all aspects of epilepsy, Dr. Goodman's research has focused on the mechanisms responsible for seizure-induced brain damage and the phenomenon of Sudden, Unexplained Death that occurs in a significant number of epileptic patients. He is an expert in experimental models of Status Epilepticus and the use of immunocytochemistry to assess brain damage after seizures, stroke and trauma. Dr. Goodman is currently a member of the Scientific Programming Committee for the Annual Meeting of the American Epilepsy Society. He is also a Visiting Associate Professor in the Department of Physiology and Pharmacology at SUNY Downstate Medical Center.
Helen E. Scharfman,
Ph.D.
Dr. Scharfman has co-authored over
100 articles, abstracts and reviews and has co-edited two books,
all in the field of neuroscience. Dr. Scharfman is a graduate
of Vassar College, where she received her B.A. in Biopsychology,
and the Uniformed Services University of Health Sciences, where
she received her Ph.D. in Pharmacology. Her training continued
with a postdoctoral fellowship in Neurophysiology at the University
of Washington, Seattle, and subsequently as a Research Associate
at SUNY Stony Brook in Neurobiology and Behavior. Her current
interests include the structure and function of limbic and cortical
brain centers such as the hippocampus, the neurobiological basis
of diseases such as epilepsy and Alzheimer's disease, and recovery
from brain and spinal cord injury, including phenomena such
as neurogenesis and neuroplasticity. Dr. Scharfman currently
is funded by several grants, four from the National Institutes
of Health (NIH) and one from the Human Frontiers Science Organization,
an international funding agency that supports international
collaborations.
|
